Postmarketing Surveillance Study for a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV) in Republic of Korea
Latest Information Update: 30 Nov 2018
Price :
$35 *
At a glance
- Drugs Japanese encephalitis vaccine (Primary)
- Indications Japanese encephalitis
- Focus Adverse reactions
- Sponsors Sanofi Pasteur
- 26 Nov 2018 Status changed from recruiting to completed.
- 27 Jul 2017 Status changed from active, no longer recruiting to recruiting.
- 28 Jun 2017 Planned End Date changed from 1 Dec 2019 to 29 Nov 2017.